Advertise on podcast: Decera Clinical Education Medical Specialties Podcast

Listen in as Nancy Reau, MD, reviews key highlights of the most impactful primary biliary cholangitis (PBC) research and gain insights on how to apply these new advances to clinical practice.  Topics covered include: Treatment GoalsLong-term Data With PPAR AgonistsInvestigational Therapies for PruritusPresenter:  Nancy Reau, MD Professor of Medicine Richard B. Capps Chair of Hepatology Chief, Section of Hepatology Associate Director, Solid Organ Transplantation Rush University Medical Center Chicago, Illinois To download the accompanying slides, visit the program page for this episode:  https://bit.ly/4b2d6YD   Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Listen in as Jay H. Shubrook, DO, FACOFP, FAAFP, and Chrisopher Weber, MD, FAAP, FACP, CSCS, daBOM, FOMA, discuss the latest advances in caring for patients with overweight or obesity in the primary care setting, including: The Lancet Commission’s new obesity definitions and diagnostic criteriaKey data on incretin-based antiobesity medications like semaglutide and tirzepatideBest practices for patient discussionsStrategies for incorporating new evidence in your primary care practicePresenters Jay H. Shubrook, DO, FACOFP, FAAFP Professor and Diabetologist Department of Clinical Sciences and Community Health Touro University California College of Osteopathic Medicine Vallejo, California Christopher Weber, MD, FAAP, FACP, CSCS, daBOM, FOMA Bariatric Services Medical Director, Ascension Wisconsin Obesity Medicine Director, Ascension Columbia St Mary’s Bariatric Center Trustee, Obesity Medicine Association Adjunct Assistant Professor of Pediatrics Medical College of Wisconsin Milwaukee, Wisconsin Link to full program: https://bit.ly/4rG7QQp Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Historically, key symptoms of primary biliary cholangitis (PBC), such as pruritus and fatigue, have been understudied and undertreated. Listen now to learn how symptom management should be considered independently of PBC management, and how new therapeutic agents can help. Topics covered include: Mechanisms of pruritus and fatigue in PBCNonpharmacologic treatment optionsAn overview of clinical trial data supporting second-line agents for symptom management:BezafibrateElafibranorSeladelparInvestigational agents:VolixibatLinerixibatSetanaxibThis episode is the third of 3 recap podcasts, featuring audio from our live satellite symposium, Raising the Bar: Innovations in PBC Care. For the full on-demand webcast of this satellite symposium, and to download the accompanying slides, visit the program page for this episode: https://bit.ly/44ZJ5os Presenters: Christopher L. Bowlus, MD Lena Valente Professor and Chief Division of Gastroenterology and Hepatology School of Medicine University of California Davis Sacramento, California Aparna Goel, MD Clinical Associate Professor of Medicine Division of Gastroenterology and Hepatology Stanford University Palo Alto, California Aliya F. Gulamhusein, MD,  MPH, FRCPC Professorship in PSC Research Clinician Investigator, Toronto General Hospital Assistant Professor, University of Toronto Division of Gastroenterology and Hepatology University Health Network Toronto, Canada Get access to all of our new episodes by subscribing to the Decera Clinical Education Medical Specialties Podcast on Apple Podcasts, YouTube Music, or Spotify. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

New therapeutic agents for second-line treatment are raising the bar for primary biliary cholangitis (PBC) management. Listen now to learn how to incorporate these new agents into clinical practice and how these agents will impact attainment of treatment goals. Topics covered include: Available agents for second-line treatment of PBC An overview of clinical trial data supporting second-line agents:Obeticholic acid (OCA)BezafibrateElafibranorSeladelparThis episode is the second of 3 recap podcasts, featuring audio from our live satellite symposium, Raising the Bar: Innovations in PBC Care. For the full on-demand webcast of this satellite symposium, and to download the accompanying slides, visit the program page for this episode: https://bit.ly/48MEc3r Presenters: Christopher L. Bowlus, MD Lena Valente Professor and Chief Division of Gastroenterology and Hepatology School of Medicine University of California Davis Sacramento, California Aparna Goel, MD Clinical Associate Professor of Medicine Division of Gastroenterology and Hepatology Stanford University Palo Alto, California Aliya F. Gulamhusein, MD, MPH, FRCPC Professorship in PSC Research Clinician Investigator, Toronto General Hospital Assistant Professor, University of Toronto Division of Gastroenterology and Hepatology University Health Network Toronto, Canada Get access to all of our new episodes by subscribing to the Decera Clinical Education Medical Specialties Podcast on Apple Podcasts, YouTube Music, or Spotify. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Advancements in our understanding of primary biliary cholangitis (PBC) and new therapeutic agents have reshaped the care landscape of PBC. Listen now to learn how these developments are helping to redefine and elevate treatment goals. Topics covered include: How and when to assess treatment responseRisk factors in PBCBiochemical treatment response and fibrosis stage as predictors of transplant-free survivalDynamics of liver stiffness measurements and clinical outcomes in PBC The importance of bilirubin and alkaline phosphatase normalizationThis episode is the first of 3 recap podcasts, featuring audio from our live satellite symposium, Raising the Bar: Innovations in PBC Care. For the full on-demand webcast of this satellite symposium, and to download the accompanying slides, visit the program page for this episode: https://bit.ly/44ZJ5os Presenters: Christopher L. Bowlus, MD Lena Valente Professor and Chief Division of Gastroenterology and Hepatology School of Medicine University of California Davis Sacramento, California Aparna Goel, MD Clinical Associate Professor of Medicine Division of Gastroenterology and Hepatology Stanford University Palo Alto, California Aliya F. Gulamhusein, MD, MPH, FRCPC Professorship in PSC Research Clinician Investigator, Toronto General Hospital Assistant Professor, University of Toronto Division of Gastroenterology and Hepatology University Health Network Toronto, Canada Get access to all of our new episodes by subscribing to the Decera Clinical Education Medical Specialties Podcast on Apple Podcasts, YouTube Music, or Spotify.   Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Join expert faculty, Dr Alan Bonder and Dr Stuart Gordon, to learn more about key gaps in PBC management and how these shortfalls can be addressed through identification of appropriate biochemical goals, proper assessment and management of PBC symptoms, and current second-line therapies.  Presenters: Alan Bonder, MD, AGAF Associate Professor of Medicine Medical Director of Liver Transplant Beth Israel Deaconess Medical Center Department of Gastroenterology Harvard Medical School Boston, Massachusetts Stuart C. Gordon, MD, FAASLD Professor of Medicine Wayne State University School of Medicine Professor of Medicine Michigan State University College of Medicine Henry Ford Health Detroit, Michigan Link to full program: https://bit.ly/3M29pI1 Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, YouTube Music, or Spotify. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Recent advances in primary biliary cholangitis (PBC) care have resulted in a new focus on personalized care and symptom management. Tune in to learn from patient advocate, Maria G. Morais, RN, how you can integrate patient insights and priorities into treatment plans for PBC. Topics covered include: The Canadian PBC Society Survey: Comorbidities and Treatment GoalsDefining and Achieving Goal-Driven Care for PBCRecent Advances in PBC ManagementNewer Agents for Second-line Treatment of PBCPresenters: Maria G. Morais, RN PBC Transplant Patient VP Patient Advocacy Canadian PBC Society Toronto, Canada Link to full program: https://bit.ly/44ySoL3 Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, YouTube Music, or Spotify.  Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Tune in to listen as expert faculty, Dr Christopher L. Bowlus and Dr Sonal Kumar, discuss recent developments in treating primary biliary cholangitis (PBC) with new and emerging agents, as well as strategies to integrate these advances into clinical practice. Topics covered include:  Methods of Assessing PBC Disease ProgressionNewer Agents for Second-line Treatment of PBCPrioritizing Symptom Management and Quality of Life With PBC TreatmentPresenters: Christopher L. Bowlus, MD Lena Valenta Professor and Chief Division of Gastroenterology and Hepatology School of Medicine  University of California Davis  Sacramento, California Sonal Kumar, MD, MPH Assistant Professor of Medicine Division of Gastroenterology and Hepatology Weill Cornell Medical College New York, New York Link to full program:  https://bit.ly/43nHx6U Get access to all of our new podcasts by subscribing to the CCO Medical Specialties Podcast on Apple Podcasts, YouTube Music, or Spotify.       Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Listen as pulmonologist Peter Dicpinigaitis discusses his approach to the diagnosis and management of patients with refractory chronic cough in the context of a clinically relevant case and provides insights regarding emerging therapies. Presenter Peter Dicpinigaitis, MD Professor of Medicine Albert Einstein College of Medicine Division of Critical Care Medicine Montefiore Medical Center Director, Montefiore Cough Center Bronx, New York Link to full program: https://bit.ly/4kweynG Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Listen as Michael S. Benninger, MD, describes his approach to the diagnosis and management of chronic cough and refractory chronic cough in the context of a clinically relevant case. Presenter Michael S. Benninger, MD Professor of Otolaryngology-Head and Neck Surgery Lerner College of Medicine The Cleveland Clinic President, International Association of Phonosurgery Cleveland, Ohio Link to full program: https://bit.ly/4kweynG Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Listen in as Joseph Kim, MD, MPH, MBA, and Colten Bracken, MD, FAAFP, discuss how to integrate comprehensive diabetes management to improve the quality of their obesity care delivery, including:  Documenting obesity as a diagnosis for patients with diabetes when appropriateStreamlining processes to ensure patients return for follow-upDedicating a care manager to initiate patient outreachImplementing pharmacotherapy strategies to help patients control their A1C and achieve weight loss simultaneously.Presenters Joseph Kim, MD, MPH, MBA President Q Synthesis, LLC Newtown, Pennsylvania Colten Bracken, MD, FAAFP Board of Directors for RHAU & UAFP Owner/Medical Director Main Street Family Medicine, PLLC Enterprise, Utah Link to full program:  https://bit.ly/3IBFZi5 Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode, Palak J. Trivedi, BSc, MBBS, PhD, MRCP, ESEGH​, discusses the most recent developments in primary biliary cholangitis (PBC) treatment, including cutting-edge data on new and emerging agents and how these updates may be integrated into your practice. Topics include: Steatotic liver disease and PBCVibration-controlled transient elastography (VCTE) and discordant biochemical responses in PBCPPAR agonists and IBATs for PBC treatment  Presenter: Palak J. Trivedi, BSc, MBBS, PhD, MRCP, ESEGH Associate Professor NIHR Birmingham BRC University of Birmingham Consultant Hepatologist, Liver Unit University Hospitals Birmingham Birmingham, United Kingdom   Link to full program:  https://bit.ly/44ySoL3 Follow along with the slides:  https://bit.ly/3IvwQrj Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify . Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode, Daniel C. Butler, MD, and Shawn G. Kwatra, MD, discuss the practical considerations for using IL-13 inhibitors to treat patients with moderate to severe atopic dermatitis, including: Patient candidacy considerationsTreatment advancement strategies that go beyond topical therapiesThe importance of patient-centered care that address patients’ fears and needsA detailed patient case to highlight take home pointsPresenter Daniel C. Butler, MD​ Assistant Dean Student Affairs​ University of Arizona College of Medicine – Tucson​ Tucson, Arizona Shawn G. Kwatra, MD​ Dr. Joseph W. Burnett Endowed Professor and Chair ​ Department of Dermatology​ University of Maryland School of Medicine​ Baltimore, Maryland Program page: https://bit.ly/4kTP04D Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode, Andrew F. Alexis, MD, MPH; Daniel C. Butler, MD; and Shawn G. Kwatra, MD, discuss IL-13 inhibition for treating patients with moderate to severe atopic dermatitis (AD), including: The available biologic therapies that specifically target IL-13Where these agents fall in the 2024 American Academy of Dermatology treatment algorithmHow these agents compare to other AD therapies like topical corticosteroids and oral JAK inhibitorsA detailed patient case to highlight take home pointsPresenter Andrew F. Alexis, MD, MPH​ Professor of Clinical Dermatology​ Weill Cornell Medical College ​ New York, New York Daniel C. Butler, MD​ Assistant Dean Student Affairs​ University of Arizona College of Medicine – Tucson​ Tucson, Arizona Shawn G. Kwatra, MD​ Dr. Joseph W. Burnett Endowed Professor and Chair ​ Department of Dermatology​ University of Maryland School of Medicine​ Baltimore, Maryland Program page: https://bit.ly/4kTP04D Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Listen in as Joseph Kim, MD, MPH, MBA; Manish Shah, MD; Martha Grugel, MA, discuss how they manage the prior authorization process for antiobesity agents to improve the quality of their care delivery, including: The information to collect during patient visitsThe available resources to help you submit prior authorizationsThe supporting documents that are often necessary to accompany prior authorizationsHow to address denials and appealsWhen to access manufacturer-based or foundation-based financial assistancePresenters Joseph Kim, MD, MPH, MBA President Q Synthesis, LLC Newtown, Pennsylvania Manish Shah, MD Clinical Associate Faculty MS1 Preceptor University of Florida College of Medicine Gainesville, Florida Martha Grugel, MA Medical Assistant Wesley Chapel, Florida Link to full program:  https://bit.ly/45P0v8z Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.